Layton Patrick Mills
Founder bij CANNPAL ANIMAL THERAPEUTICS LIMITED
Profiel
Layton Patrick Mills is the founder of CannPal Animal Therapeutics Ltd.
which was founded in 2016.
He held the titles of Chief Executive Officer, Director & MD at the time of founding.
Currently, he is a Non-Executive Director at MGC Pharmaceuticals Ltd.
where he started in 2023.
In 2021, he was the Chief Executive Officer at AusCann Group Holdings Ltd.
until 2022.
Actieve functies van Layton Patrick Mills
| Bedrijven | Functie | Begin |
|---|---|---|
| CANNPAL ANIMAL THERAPEUTICS LIMITED | Founder | 03-06-2016 |
| ARGENT BIOPHARMA LIMITED | Director/Board Member | 01-06-2023 |
Eerdere bekende functies van Layton Patrick Mills
| Bedrijven | Functie | Einde |
|---|---|---|
| AUSCANN GROUP HOLDINGS LTD | Chief Executive Officer | 13-09-2022 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ARGENT BIOPHARMA LIMITED | Health Technology |
| AUSCANN GROUP HOLDINGS LTD | Process Industries |
| Bedrijven in privébezit | 1 |
|---|---|
CannPal Animal Therapeutics Ltd.
 CannPal Animal Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology CannPal Animal Therapeutics Ltd. pharmaceutical company, which focuses on animal health. It researches, develops, and commercializes regulatory approved cannabinoid-derived therapeutic pet products for cats and dogs. The company was founded by Layton Mills on June 3, 2016 and is headquartered in Double Bay, Australia. | Health Technology |
